Cited 129 times in
Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.